Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Multi-Center Single Dose Study to Evaluate the Safety and Effectiveness of URG101 Compared With the Individual Components Lidocaine and Heparin in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated:  12/31/1969
Rutgers Women's Health Clinic
mi
from
New Brunswick, NJ
Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Multi-Center Single Dose Study to Evaluate the Safety and Effectiveness of URG101 Compared With the Individual Components Lidocaine and Heparin in Subjects With Interstitial Cystitis/Bladder Pain Syndrome
Status: Enrolling
Updated: 12/31/1969
Rutgers Women's Health Clinic
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Intraoperative Oxygen Concentration and Neurocognition After Cardiac Surgery
The Relationship Between Administered Oxygen Levels and Arterial Partial Oxygen Pressure to Neurocognition in Post-operative Mechanically Ventilated Cardiac Surgical Patients
Status: Enrolling
Updated:  12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Intraoperative Oxygen Concentration and Neurocognition After Cardiac Surgery
The Relationship Between Administered Oxygen Levels and Arterial Partial Oxygen Pressure to Neurocognition in Post-operative Mechanically Ventilated Cardiac Surgical Patients
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Medication-Assisted Treatment for Youth With Substance Use Disorders
Medication-Assisted Treatment for Youth With Substance Use Disorders
Status: Enrolling
Updated:  12/31/1969
New York State Psychiatric Insitute
mi
from
New York, NY
Medication-Assisted Treatment for Youth With Substance Use Disorders
Medication-Assisted Treatment for Youth With Substance Use Disorders
Status: Enrolling
Updated: 12/31/1969
New York State Psychiatric Insitute
mi
from
New York, NY
Click here to add this to my saved trials
Medication-Assisted Treatment for Youth With Substance Use Disorders
Medication-Assisted Treatment for Youth With Substance Use Disorders
Status: Enrolling
Updated:  12/31/1969
New York State Psychiatric Institute
mi
from
New York, NY
Medication-Assisted Treatment for Youth With Substance Use Disorders
Medication-Assisted Treatment for Youth With Substance Use Disorders
Status: Enrolling
Updated: 12/31/1969
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders
Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders
Status: Enrolling
Updated:  12/31/1969
Ambulatory Research Center (ARC)
mi
from
Minneapolis, MN
Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders
Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders
Status: Enrolling
Updated: 12/31/1969
Ambulatory Research Center (ARC)
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders
Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders
Status: Enrolling
Updated:  12/31/1969
Center for Magnetic Resonance Research
mi
from
Minneapolis, MN
Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders
Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders
Status: Enrolling
Updated: 12/31/1969
Center for Magnetic Resonance Research
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Navigation Services to Avoid Rehospitalization (NavSTAR)
Navigation Services to Avoid Rehospitalization (NavSTAR) Among Substance Users
Status: Enrolling
Updated:  12/31/1969
University of Maryland Medical Center
mi
from
Baltimore, MD
Navigation Services to Avoid Rehospitalization (NavSTAR)
Navigation Services to Avoid Rehospitalization (NavSTAR) Among Substance Users
Status: Enrolling
Updated: 12/31/1969
University of Maryland Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Distress Tolerance and HIV Prevention With XR-NTX Initiation in Opioid Dependence
Distress Tolerance and HIV Prevention With XR-NTX Initiation in Opioid Dependence
Status: Enrolling
Updated:  12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Distress Tolerance and HIV Prevention With XR-NTX Initiation in Opioid Dependence
Distress Tolerance and HIV Prevention With XR-NTX Initiation in Opioid Dependence
Status: Enrolling
Updated: 12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Emotion Recognition Modification for Bipolar Disorder
Emotion Recognition Modification for Bipolar Disorder
Status: Enrolling
Updated:  12/31/1969
The Zucker Hillside Hospital
mi
from
Glen Oaks, NY
Emotion Recognition Modification for Bipolar Disorder
Emotion Recognition Modification for Bipolar Disorder
Status: Enrolling
Updated: 12/31/1969
The Zucker Hillside Hospital
mi
from
Glen Oaks, NY
Click here to add this to my saved trials
Robot-Mediated Intervention for Children With Autism Spectrum Disorders
Robot-Mediated Social Skills Intervention for Children With Autism Spectrum Disorders
Status: Enrolling
Updated:  12/31/1969
Kennedy Krieger Institute
mi
from
Baltimore, MD
Robot-Mediated Intervention for Children With Autism Spectrum Disorders
Robot-Mediated Social Skills Intervention for Children With Autism Spectrum Disorders
Status: Enrolling
Updated: 12/31/1969
Kennedy Krieger Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
Stay Healthy In Nature Everyday: Family Nature Outings in a Low Income Population
Stay Healthy In Nature Everyday: a Randomized Controlled Trial of the Effect of Family Nature Outings on Stress and Physical Inactivity in a Low Income Population
Status: Enrolling
Updated:  12/31/1969
UCSF Benioff Children's Hospital Oakland Primary Care Clinic
mi
from
Oakland, CA
Stay Healthy In Nature Everyday: Family Nature Outings in a Low Income Population
Stay Healthy In Nature Everyday: a Randomized Controlled Trial of the Effect of Family Nature Outings on Stress and Physical Inactivity in a Low Income Population
Status: Enrolling
Updated: 12/31/1969
UCSF Benioff Children's Hospital Oakland Primary Care Clinic
mi
from
Oakland, CA
Click here to add this to my saved trials
Effectiveness of Two Self Assessment Tools: KIOS-Bipolar or eMoods
Comparative Effectiveness of Two Self Assessment Tools: KIOS-Bipolar or eMoods: A Randomized, Open 52 Week Study for Persons With Bipolar Disorder
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Effectiveness of Two Self Assessment Tools: KIOS-Bipolar or eMoods
Comparative Effectiveness of Two Self Assessment Tools: KIOS-Bipolar or eMoods: A Randomized, Open 52 Week Study for Persons With Bipolar Disorder
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Buprenorphine and Substance Abuse Services for Prescription Opioid Dependence
Buprenorphine and Substance Abuse Services for Prescription Opioid Dependence
Status: Enrolling
Updated:  12/31/1969
Kaiser Sacramento Chemical Dependency Recovery Program
mi
from
Sacramento, CA
Buprenorphine and Substance Abuse Services for Prescription Opioid Dependence
Buprenorphine and Substance Abuse Services for Prescription Opioid Dependence
Status: Enrolling
Updated: 12/31/1969
Kaiser Sacramento Chemical Dependency Recovery Program
mi
from
Sacramento, CA
Click here to add this to my saved trials
Motivated Behavior in Adults With and Without ADHD
Motivated Behavior in Adults With and Without ADHD
Status: Enrolling
Updated:  12/31/1969
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Motivated Behavior in Adults With and Without ADHD
Motivated Behavior in Adults With and Without ADHD
Status: Enrolling
Updated: 12/31/1969
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Interpretation Bias Modification for Body Dysmorphic Disorder
Evaluation of an Internet-Based Treatment for Body Dysmorphic Disorder
Status: Enrolling
Updated:  12/31/1969
Florida State University Psychology Department
mi
from
Tallahassee, FL
Interpretation Bias Modification for Body Dysmorphic Disorder
Evaluation of an Internet-Based Treatment for Body Dysmorphic Disorder
Status: Enrolling
Updated: 12/31/1969
Florida State University Psychology Department
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Little Rock, AR
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Study Site
mi
from
Rogers, AR
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Study Site
mi
from
Rogers, AR
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Cerritos, CA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Cerritos, CA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Culver City, CA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Culver City, CA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Garden Grove, CA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
National City, CA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
National City, CA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Oakland, CA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Oakland, CA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Study Site
mi
from
Oceanside, CA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Study Site
mi
from
Oceanside, CA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Orange, CA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Orange, CA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Pico Rivera, CA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Pico Rivera, CA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Riverside, CA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Riverside, CA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
San Diego, CA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
San Marcos, CA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
San Marcos, CA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Research Site
mi
from
Santa Rosa, CA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Research Site
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Colorado Springs, CO
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Bradenton, FL
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Bradenton, FL
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Jacksonville, FL
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Lauderhill, FL
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Lauderhill, FL
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Research Site
mi
from
Miami, FL
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Research Site
mi
from
Miami, FL
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
North Miami, FL
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
North Miami, FL
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Orlando, FL
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Orlando, FL
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Atlanta, GA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Chicago, IL
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Hoffman Estates, IL
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Lake Charles, LA
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Las Vegas, NV
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Study Site
mi
from
Berlin, NJ
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Study Site
mi
from
Berlin, NJ
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Cherry Hill, NJ
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Marlton, NJ
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Marlton, NJ
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Toms River, NJ
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Toms River, NJ
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Research Site
mi
from
Brooklyn, NY
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Research Site
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Cedarhurst, NY
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Cedarhurst, NY
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Site
mi
from
Rochester, NY
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Site
mi
from
Rochester, NY
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Staten Island, NY
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Staten Island, NY
Click here to add this to my saved trials
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Site
mi
from
Cleveland, OH
Clinical Trial Evaluating ITI-007 as a Monotherapy for the Treatment of Bipolar Depression
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Site
mi
from
Cleveland, OH
Click here to add this to my saved trials